Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ultrashort Biotechnology Proshares (BIS)

30.9742   -0.386 (-1.23%) 10-01 09:16
Open: 31.14 Pre. Close: 31.36
High: 31.43 Low: 30.48
Volume: 47,659 Market Cap: 0M
BIS was created on 04/08/10 by ProShares. The ETF provides -2x exposure to a market-cap weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 31.798 - 31.989 31.989 - 32.131
Low: 30.594 - 30.847 30.847 - 31.035
Close: 30.839 - 31.211 31.211 - 31.488

Technical analysis

as of: 2020-09-30 4:39:13 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 39.76     One year: 42.62
Support: Support1: 30.09    Support2: 25.03
Resistance: Resistance1: 34.05    Resistance2: 36.49
Pivot: 32.42
Moving Average: MA(5): 32.13     MA(20): 32.81
MA(100): 32.95     MA(250): 47.83
MACD: MACD(12,26): -0.31     Signal(9): -0.14
Stochastic oscillator: %K(14,3): 22.95     %D(3): 32.38
RSI: RSI(14): 44.10
52-week: High: 84.92  Low: 27.84  Change(%): -62.9
Average Vol(K): 3-Month: 9700  10-Days: 4831

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BIS has closed above bottom band by 30.6%. Bollinger Bands are 26.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 11 Sep 2020
Form 485APOS PROSHARES TRUST - StreetInsider.com

Tue, 04 Aug 2020
ProShares Announces ETF Share Splits - Business Wire

Fri, 08 May 2020
ARK Genomic Revolution Multi-Sector ETF: An Overbought But Promising Niche Play - Seeking Alpha

Tue, 25 Jun 2019
3 Inverse Sector ETFs for Market Bears - Investopedia

Thu, 25 Oct 2018
Top 19 Biotechnology ETFs - ETFdb.com

Sun, 17 Jul 2016
18 Most Traded Inverse ETFs by Sector in 2016 (FAZ, ERY) - Investopedia

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector: 
Industry: 
Shares Out. (M)
Shares Float (M) 1
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.